Project Number 1RF1NS124203-01 Agency/Funding Organization NINDS Funding Year 2021 View Full Project Details for In vivo modelling and therapy development for stathmin-2 loss in TDP-43 proteinopathies Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 5. Other Proteinopathies b. TDP-43 and FUS Researcher and Organization Principal Investigator LAGIER-TOURENNE, CLOTILDE Principal Investigator First Name CLOTILDE Principal Investigator Last Name LAGIER-TOURENNE Awardee Organization MASSACHUSETTS GENERAL HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-20-185: NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed) FY Overall Cost $2,507,311 Funding Organization Agency/Funding Organization NINDS Funding Organization Country United States Program Official GUBITZ, AMELIE
